Impact of hyperglycemia at admission in patients with acute ST-segment elevation myocardial infarction as assessed by contrast-enhanced MRI

Clinical Research in Cardiology

Volumn 100, Issue 8, 2011, Pages 649-659

  Jensen, Christoph J ^a   Eberle, Holger C ^a   Nassenstein, Kai ^b   Schlosser, Thomas ^b   Farazandeh, Mani ^a   Naber, Christoph K ^a   Sabin, Georg V ^a   Bruder, Oliver ^a  

^a ELISABETH KRANKENHAUS ESSEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

CMR; Hyperglycemia; LGE; Microvascular obstruction; Myocardial infarction; STEMI

Indexed keywords

GADODIAMIDE; GADOLINIUM; GLUCOSE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BODY WEIGHT; CARDIAC IMAGING; CARDIAC PATIENT; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CORONARY ARTERY OBSTRUCTION; DEATH; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART EJECTION FRACTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RECEIVER OPERATING CHARACTERISTIC; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ARTERIAL OCCLUSIVE DISEASES; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GADOLINIUM; HUMANS; HYPERGLYCEMIA; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; VENTRICULAR FUNCTION, LEFT;

EID: 80051796308     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-011-0290-7     Document Type: Article

References (46)

1. R Marfella M Verza L Coppola 2005 Myocardial infarction and hyperglycemia Am J Cardiol 96 1468 16275205 10.1016/j.amjcard.2005.07.034 (Pubitemid 41566639)
2. C Nordin R Amiruddin L Rucker J Choi A Kohli PR Marantz 2005 Diabetes and stress hyperglycemia associated with myocardial infarctions at an urban municipal hospital: prevalence and effect on mortality Cardiol Rev 13 223 230 16106183 10.1097/01.crd.0000137251.77175.6a (Pubitemid 41197250)
3. SE Capes D Hunt K Malmberg HC Gerstein 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: A systematic overview Lancet 355 773 778 10711923 10.1016/S0140-6736(99)08415-9 1:STN:280:DC%2BD3c7nsFSrtQ%3D%3D (Pubitemid 30128815)
4. M Ishihara E Kagawa I Inoue, et al. 2007 Impact of admission hyperglycemia and diabetes mellitus on short- and long-term mortality after acute myocardial infarction in the coronary intervention era Am J Cardiol 99 1674 1679 17560874 10.1016/j.amjcard.2007.01.044 (Pubitemid 46874310)
5. I Stranders M Diamant RE van Gelder, et al. 2004 Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus Arch Intern Med 164 982 988 15136307 10.1001/archinte.164.9.982 (Pubitemid 38581518)
6. S Lavi M Kapeliovich L Gruberg, et al. 2008 Hyperglycemia during acute myocardial infarction in patients who are treated by primary percutaneous coronary intervention: impact on long-term prognosis Int J Cardiol 123 117 122 17367882 10.1016/j.ijcard.2006.11.222 (Pubitemid 350250888)
7. A Cochet M Zeller A Lalande, et al. 2008 Utility of cardiac magnetic resonance to assess association between admission hyperglycemia and myocardial damage in patients with reperfused ST-segment elevation myocardial infarction J Cardiovasc Magn Reson 10 2 18272004 10.1186/1532-429X-10-2
8. K Iwakura H Ito M Ikushima, et al. 2003 Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction J Am Coll Cardiol 41 1 7 12570936 10.1016/S0735-1097(02)02626-8 1:CAS:528: DC%2BD3sXpsVGrsw%3D%3D (Pubitemid 36044395)
9. XH Shen SQ Jia HW Li 2006 The influence of admission glucose on epicardial and microvascular flow after primary angioplasty Chin Med J (Engl) 119 95 102
10. Rassaf T, Nolte J, Heussen N et al (2010) Quantitation of the thickness of the non-enhanced myocardial rim predicts recovery of territorial myocardial function in chronic ischemic heart disease: A cardiac magnetic resonance imaging study. Clin Res Cardiol 99:293-300
11. Pilz G, Heer T, Graw M et al (2010) Influence of small caliber coronary arteries on the diagnostic accuracy of adenosine stress cardiac magnetic resonance imaging. Clin Res Cardiol (Epub ahead of print)
12. O Bruder S Schneider D Nothnagel, et al. 2009 EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase J Am Coll Cardiol 54 1457 1466 19682818 10.1016/j.jacc.2009.07.003
13. Bruder O, Wagner A, Mahrholdt H (2010) Lessons learned from the european cardiovascular magnetic resonance (EuroCMR) registry pilot phase. Curr Cardiovasc Imaging Rep 3:171-174
14. O Koeth B Mark A Kilkowski, et al. 2008 Clinical, angiographic and cardiovascular magnetic resonance findings in consecutive patients with Takotsubo cardiomyopathy Clin Res Cardiol 97 623 627 18677436 10.1007/s00392-008-0661-x
15. Merkle N, Wohrle J, Nusser T et al (2010) Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease. Clin Res Cardiol 99:21-8
16. U Muller S Nitzsche I Eitel M Gutberlet G Schuler H Thiele 2008 Covered rupture of the free left ventricular wall or "only" thrombus in a true aneurysm? Clin Res Cardiol 97 843 845 18648723 10.1007/s00392-008-0696-z
17. H Mahrholdt A Wagner TA Holly, et al. 2002 Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging Circulation 106 2322 2327 12403661 10.1161/01.CIR.0000036368.63317.1C 1:CAS:528:DC%2BD38XotV2iu7k%3D (Pubitemid 35244732)
18. RJ Kim EL Chen JA Lima RM Judd 1996 Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction Circulation 94 3318 3326 8989146 1:STN:280:DyaK2s7ktlWgtw%3D%3D (Pubitemid 26427504)
19. RJ Kim DS Fieno TB Parrish, et al. 1999 Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function Circulation 100 1992 2002 10556226 1:STN:280:DC%2BD3c%2FivVensg%3D%3D (Pubitemid 29529292)
20. RJ Kim WJ Manning 2004 Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine? Circulation 109 2476 2479 15173036 10.1161/01.CIR.0000130730.63776.69 (Pubitemid 38720542)
21. Jensen CJ, Jochims M, Hunold P, Sabin GV, Schlosser T, Bruder O (2010) Right ventricular involvement in acute left ventricular myocardial infarction: prognostic implications of MRI findings. AJR Am J Roentgenol 194:592-598
22. CJ Jensen D Bleckmann HC Eberle, et al. 2009 A simple MR algorithm for estimation of myocardial salvage following acute ST segment elevation myocardial infarction Clin Res Cardiol 98 651 656 19685002 10.1007/s00392-009-0051-z
23. C Merten H Steen C Kulke E Giannitsis HA Katus 2008 Contrast-enhanced magnetic resonance imaging reveals early decrease of transmural extent of reperfused acute myocardial infarction Clin Res Cardiol 97 913 916 18853097 10.1007/s00392-008-0710-5
24. KC Wu EA Zerhouni RM Judd, et al. 1998 Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction Circulation 97 765 772 9498540 1:STN:280: DyaK1c7lvVejtw%3D%3D (Pubitemid 28135339)
25. CE Rochitte JA Lima DA Bluemke, et al. 1998 Magnitude and time course of microvascular obstruction and tissue injury after acute myocardial infarction Circulation 98 1006 1014 9737521 1:STN:280:DyaK1cvgslGguw%3D%3D (Pubitemid 28446654)
26. KC Wu RJ Kim DA Bluemke, et al. 1998 Quantification and time course of microvascular obstruction by contrast-enhanced echocardiography and magnetic resonance imaging following acute myocardial infarction and reperfusion J Am Coll Cardiol 32 1756 1764 9822106 10.1016/S0735-1097(98)00429-X 1:STN:280:DyaK1M%2Fjsl2jsg%3D%3D (Pubitemid 28560223)
27. O Bruder F Breuckmann C Jensen, et al. 2008 Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen" Herz 33 136 142 18344033 10.1007/s00059-008-3102-8 (Pubitemid 351437851)
28. de Waha S, Desch S, Eitel I et al (2010) Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 31:2660-2668
29. L Ryden E Standl M Bartnik, et al. 2007 Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur Heart J 28 88 136 17220161 10.1093/eurheartj/ehm124 1:CAS:528:DC%2BD2sXitlaiur8%3D (Pubitemid 47355991)
30. American Diabetes Association 2003 Screening for type 2 diabetes Diabetes Care 26 Suppl 1 S21 S24
31. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26 (Suppl 1)
32. OP Simonetti RJ Kim DS Fieno, et al. 2001 An improved MR imaging technique for the visualization of myocardial infarction Radiology 218 215 223 11152805 1:STN:280:DC%2BD3MzitFCntg%3D%3D (Pubitemid 32151298)
33. MG Friedrich H Abdel-Aty A Taylor J Schulz-Menger D Messroghli R Dietz 2008 The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance J Am Coll Cardiol 51 1581 1587 18420102 10.1016/j.jacc.2008.01.019 (Pubitemid 351508364)
34. Weir RA, Murphy CA, Petrie CJ et al (2010) Microvascular obstruction remains a portent of adverse remodeling in optimally treated patients with left ventricular systolic dysfunction after acute myocardial infarction. Circ Cardiovasc Imaging 3:360-367
35. F Van de Werf J Bax A Betriu, et al. 2008 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European society of cardiology Eur Heart J 29 2909 2945 19004841 10.1093/eurheartj/ehn416
36. M Lankisch R Futh H Gulker, et al. 2008 Screening for undiagnosed diabetes in patients with acute myocardial infarction Clin Res Cardiol 97 753 759 18491170 10.1007/s00392-008-0674-5
37. R Marfella K Esposito R Giunta, et al. 2000 Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia Circulation 101 2247 2251 10811590 1:CAS:528:DC%2BD3cXjvFSrt7c%3D (Pubitemid 30317125)
38. MI Worthley AS Holmes SR Willoughby, et al. 2007 The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration J Am Coll Cardiol 49 304 310 17239711 10.1016/j.jacc.2006.08.053 1:CAS:528:DC%2BD2sXnslyisA%3D%3D (Pubitemid 46097375)
39. JR Kersten WG Toller JP Tessmer PS Pagel DC Warltier 2001 Hyperglycemia reduces coronary collateral blood flow through a nitric oxide-mediated mechanism Am J Physiol Heart Circ Physiol 281 H2097 H2104 11668071 1:CAS:528: DC%2BD3MXosFylsbk%3D
40. M Ishihara I Inoue T Kawagoe, et al. 2003 Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with a first anterior wall acute myocardial infarction Am J Cardiol 92 288 291 12888134 10.1016/S0002-9149(03)00627-1 (Pubitemid 36897712)
41. V Hombach N Merkle HA Kestler, et al. 2008 Characterization of patients with acute chest pain using cardiac magnetic resonance imaging Clin Res Cardiol 97 760 767 18516488 10.1007/s00392-008-0675-4
42. M Neizel S Futterer H Steen, et al. 2009 Predicting microvascular obstruction with cardiac troponin T after acute myocardial infarction: a correlative study with contrast-enhanced magnetic resonance imaging Clin Res Cardiol 98 555 562 19582365 10.1007/s00392-009-0041-1 1:CAS:528: DC%2BD1MXhtFCgt7nM
43. G Van den Berghe PJ Wouters R Bouillon, et al. 2003 Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control Crit Care Med 31 359 366 12576937 10.1097/01.CCM.0000045568.12881.10 (Pubitemid 36232926)
44. NW Cheung VW Wong M McLean 2006 Insulin infusion therapy for myocardial infarction Expert Opin Pharmacother 7 2495 2503 17150004 10.1517/14656566.7.18. 2495 1:CAS:528:DC%2BD28Xht1OntLvJ (Pubitemid 44932454)
45. NW Cheung VW Wong M McLean 2006 The hyperglycemia: intensive insulin infusion in infarction (HI-5) study: A randomized controlled trial of insulin infusion therapy for myocardial infarction Diabetes Care 29 765 770 16567812 10.2337/diacare.29.04.06.dc05-1894 1:CAS:528:DC%2BD28XjslOntr8%3D (Pubitemid 44115291)
46. K Malmberg L Ryden H Wedel, et al. 2005 Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity Eur Heart J 26 650 661 15728645 10.1093/eurheartj/ehi199 1:CAS:528:DC%2BD2MXksFGnsrk%3D (Pubitemid 40516876)